Kangdong Liu Selected Research

Biomarkers (Surrogate Marker)

1/2024	Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy.
12/2021	AGT serves as a potential biomarker and drives tumor progression in colorectal carcinoma.
1/2020	Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
1/2020	CDK12 and PAK2 as novel therapeutic targets for human gastric cancer.
11/2017	A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.
1/2015	[Serum levels of matrix metalloproteinase 9 and 19 in the patients with pneumoconiosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kangdong Liu Research Topics

Disease

122	Neoplasms (Cancer) 04/2024 - 06/2009
47	Esophageal Squamous Cell Carcinoma 04/2024 - 12/2012
25	Carcinogenesis 04/2024 - 06/2009
16	Esophageal Neoplasms (Esophageal Cancer) 12/2022 - 12/2012
15	Lung Neoplasms (Lung Cancer) 12/2023 - 05/2015
13	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 02/2015
11	Stomach Neoplasms (Stomach Cancer) 05/2023 - 06/2018
10	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2016
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 10/2014
7	Inflammation (Inflammations) 01/2024 - 09/2016
6	Colonic Neoplasms (Colon Cancer) 04/2024 - 06/2011
5	Melanoma (Melanoma, Malignant) 01/2023 - 05/2011
5	Infections 01/2022 - 02/2008
5	Skin Neoplasms (Skin Cancer) 01/2021 - 02/2012
5	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2012
4	Carcinoma (Carcinomatosis) 11/2018 - 12/2014
4	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2011
3	COVID-19 10/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2020
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 01/2021
2	Esophagitis 01/2022 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 05/2020
2	Mouth Neoplasms (Oral Cancer) 07/2021 - 05/2018
2	Genomic Instability 01/2021 - 01/2021
2	Bone Resorption 01/2021 - 12/2016
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2009
2	Triple Negative Breast Neoplasms 09/2019 - 06/2017
2	Neoplastic Cell Transformation 12/2018 - 01/2011
2	Squamous Cell Carcinoma of Head and Neck 05/2018 - 04/2016

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2009
18	Phosphotransferases (Kinase)IBA 12/2023 - 11/2009
8	Gefitinib (Iressa)FDA Link 08/2023 - 10/2014
7	FlavonoidsIBA 01/2021 - 09/2013
6	Protein Kinases (Protein Kinase)IBA 02/2024 - 06/2011
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
6	AntioxidantsIBA 01/2023 - 04/2016
6	CateninsIBA 01/2022 - 05/2017
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 01/2020
5	Monoclonal AntibodiesIBA 06/2023 - 01/2020
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023 - 11/2011
5	EnzymesIBA 01/2023 - 07/2015
5	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 06/2012
4	IntegrinsIBA 07/2023 - 10/2011
4	AntigensIBA 01/2023 - 06/2017
4	Aurora Kinase AIBA 01/2022 - 03/2019
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2018
4	aloe emodinIBA 12/2018 - 07/2012
3	Messenger RNA (mRNA)IBA 04/2024 - 11/2017
3	Nucleotide AptamersIBA 01/2024 - 06/2021
3	ProteomeIBA 01/2023 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2019
3	CytokinesIBA 01/2022 - 01/2020
3	CarcinogensIBA 01/2022 - 11/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2021 - 05/2018
3	Therapeutic UsesIBA 04/2021 - 05/2016
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 09/2013
3	p21-Activated KinasesIBA 01/2021 - 01/2020
3	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2020 - 07/2015
3	Small Interfering RNA (siRNA)IBA 02/2018 - 06/2009
2	artenimol (dihydroartemisinin)IBA 12/2023 - 01/2020
2	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 12/2023 - 06/2016
2	ErianinIBA 12/2023 - 01/2023
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2023 - 12/2019
2	PerforinIBA 01/2023 - 01/2021
2	N- (12- cyanoindolizino(2,3- b)quinoxalin- 2- yl)thiophene- 2- carboxamideIBA 01/2023 - 12/2019
2	Granzymes (Granzyme)IBA 01/2023 - 01/2021
2	sulphorapheneIBA 01/2023 - 01/2019
2	MitogensIBA 01/2023 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 12/2022 - 06/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 01/2022
2	acetylshikoninIBA 10/2022 - 01/2020
2	costunolideIBA 10/2022 - 07/2021
2	tegaserod (Zelnorm)FDA Link 07/2022 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 05/2018
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2019
2	Eflornithine (Ornidyl)FDA Link 01/2022 - 01/2017
2	ubenimexIBA 11/2021 - 06/2019
2	IsoflavonesIBA 01/2021 - 05/2017
2	Caspase 3 (Caspase-3)IBA 10/2020 - 12/2019
2	xanthohumolIBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 07/2016
2	CaspasesIBA 01/2020 - 05/2018
2	Antimalarials (Antimalarial Agents)IBA 01/2020 - 01/2020
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020 - 09/2016
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020 - 11/2018
2	Annexin A5IBA 01/2020 - 01/2020
2	NF-kappa B (NF-kB)IBA 09/2019 - 01/2019
2	polypeptide 3 90kDa ribosomal protein S6 kinaseIBA 09/2019 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2018 - 06/2011
2	VaccinesIBA 11/2018 - 10/2016
2	eupatilinIBA 06/2018 - 09/2016
2	oridoninIBA 05/2018 - 01/2018

Therapy/Procedure

33	Therapeutics 04/2024 - 06/2009
12	Chemoprevention 05/2023 - 02/2012
7	Drug Therapy (Chemotherapy) 01/2024 - 01/2014
5	Immunotherapy 04/2024 - 01/2019
3	Oral Administration 11/2021 - 09/2018
2	Radiotherapy 01/2023 - 05/2021
2	Aftercare (After-Treatment) 01/2022 - 01/2020